Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2025 08:00 ET | Source: Australian Oilseeds Investments Pty Ltd.

Australian Oilseeds Announces Appointment of Amarjeet Singh as Chief Financial Officer

COOTAMUNDRA, Australia, March 03, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT), today announced the appointment of...
March 03, 2025 08:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
March 03, 2025 08:00 ET | Source: MBX Biosciences, Inc.

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

CARMEL, Ind., March 03, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide...
March 03, 2025 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Provides February Tigris Trial Update

152 patients enrolled TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic...
March 03, 2025 08:00 ET | Source: Artelo Biosciences

Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

SOLANA BEACH, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...
March 03, 2025 08:00 ET | Source: Norden Crown Metals Corp

Norden Discovers Gold Mineralized Porphyry Intrusion Returning 4.26 g/t Gold 850 Metres East of Sunrise Mine at the Smart Creek Project, Montana

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) -- Norden Crown Metals Corp. ("Norden Crown" or the "Company") (TSXV:NOCR, Frankfurt; 03E) provides new assay results from reconnaissance...
March 03, 2025 08:00 ET | Source: Ovid Therapeutics Inc.

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant...
March 03, 2025 08:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia

ANN ARBOR, Mich., March 03, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the...
March 03, 2025 08:00 ET | Source: Gabelli Funds

Gabelli Funds to Host 16th Annual Specialty Chemicals Symposium Thursday, March 20, 2025

GREENWICH, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds is hosting its 16th Annual Specialty Chemicals Symposium taking place at The Harvard Club in New York, NY on Thursday, March 20,...
March 03, 2025 08:00 ET | Source: Aligos Therapeutics

Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through...